A single‐center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease
2020 ◽
Vol 145
(2)
◽
pp. AB34
2017 ◽
Vol 23
(6)
◽
pp. 472-477
◽
2016 ◽
Vol 22
(11)
◽
pp. 2011-2018
◽
2020 ◽
Vol 26
(3)
◽
pp. S214
2017 ◽
Vol 23
(3)
◽
pp. S227
◽